Syntara Returns After A$10m Raise and FDA Win
Syntara (ASX:SNT) resumed trading yesterday with two pieces of good news in the same week: A$10 million in fresh capital and a…
30
30
Lumos Diagnostics (ASX: LDX) Falls Despite FDA Win- Here’s Why the Dip Could Be a Buying Opportunity
Lumos Diagnostics Falls After FDA Waiver
Lumos Diagnostics (ASX: LDX) slipped around 3.8% on Friday despite announcing one of the most important milestones in its history. The US Food and…
15
14
NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?
NeuroScientific jumps on early Crohn’s stem cell results
NeuroScientific Biopharmaceuticals (ASX: NSB)Â surged 43% on Tuesday after announcing promising early results from its stem cell program. Three out of four patients…
08
22
17
12
10
